Skip to main content
Stage 2 · industry

Stage 2 Stocks in Hospitals & Diagnostic Centres

6 NSE Hospitals & Diagnostic Centres stocks are in a confirmed uptrend — Stage 2, Weinstein's advancing phase, identified by our stage classifier (bullish, trending). Ranked by setup score, end-of-day 2026-10-16.

NSE Hospitals & Diagnostic Centres stocks in Stage 2 (uptrend), ranked by setup score, end-of-day 2026-10-16.
StockClose1DSetupWeeks in stage
YATHARTH
Yatharth Hospital & Trauma Care Services Ltd
₹992.1+0.06%6.223
LALPATHLAB
Dr. Lal PathLabs Ltd
₹1,859.9-1.34%5.619
SURAKSHA
Suraksha Diagnostic Ltd
₹306.7-0.31%5.07
VIJAYA
Vijaya Diagnostic Centre Ltd
₹1,381.7-0.41%4.422
MEDANTA
Global Health Ltd
₹1,240-2.78%3.916
NEPHROPLUS
Nephrocare Health Services Ltd
₹614.35+0.44%2.42

Every one recalculated after the close, with the exact criteria published on the page.

Stage 2 in other sectors & industries

Browse the NSE stocks in a confirmed uptrend — Stage 2, Weinstein’s advancing phase — grouped by sector and industry, ranked by setup score.